Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Tempest Therapeutics - 13 Year Stock Price History | TPST

Historical daily share price chart and data for Tempest Therapeutics since 2012 adjusted for splits and dividends. The latest closing stock price for Tempest Therapeutics as of June 17, 2025 is 6.85.
  • The all-time high Tempest Therapeutics stock closing price was 156370.00 on March 24, 2015.
  • The Tempest Therapeutics 52-week high stock price is 35.24, which is 414.5% above the current share price.
  • The Tempest Therapeutics 52-week low stock price is 5.35, which is 21.9% below the current share price.
  • The average Tempest Therapeutics stock price for the last 52 weeks is 13.63.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Tempest Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 9.3490 11.1592 12.8128 5.8600 6.8500 -36.86%
2024 31.5225 57.3300 70.7200 9.0818 10.8485 -81.03%
2023 26.0283 15.9263 127.0100 2.9900 57.2000 282.61%
2022 33.6655 70.8500 70.8500 14.9500 14.9500 -78.22%
2021 238.3839 401.7000 532.3500 68.6400 68.6400 -83.55%
2020 629.9695 1378.6500 1868.1000 273.0000 417.3000 -68.25%
2019 2039.1703 1599.9700 3334.5000 916.5000 1314.3000 -15.22%
2018 2519.7888 3948.7500 4299.7500 1363.0500 1550.2500 -62.14%
2017 4338.4410 4972.5100 5733.0100 3714.7500 4095.0000 -8.50%
2016 18627.0852 27027.0000 32935.5000 3919.5000 4475.2500 -84.34%
2015 80610.1603 134053.0000 156370.0000 24833.2000 28577.3000 -77.91%
2014 40257.3024 26646.7000 139961.0000 18749.2000 129343.0000 383.81%
2013 31648.4592 24862.5000 45630.1000 23838.8000 26734.5000 9.20%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.024B $0.000B
Tempest Therapeutics Inc. is a clinical-stage oncology company developing potentially first-in-class therapeutics which combines both targeted and immune-mediated mechanisms. Tempest Therapeutics Inc., formerly known as Millendo Therapeutics Inc., is based in Calif.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.271B 31.77
Zoetis (ZTS) United States $73.161B 27.31
Takeda Pharmaceutical (TAK) Japan $48.365B 9.54
Daiichi Sankyo, - (DSNKY) Japan $46.601B 23.51
BeOne Medicines - (ONC) Cayman Islands $29.540B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.150B 0.00
Merck (MKKGY) Germany $17.047B 12.56
Summit Therapeutics (SMMT) United States $14.690B 0.00
Shionogi (SGIOY) Japan $14.547B 14.72
United Therapeutics (UTHR) United States $12.781B 11.51
Neurocrine Biosciences (NBIX) United States $12.310B 42.37
Orion OYJ (ORINY) Finland $10.212B 27.81
IPSEN (IPSEY) France $10.004B 0.00
Corcept Therapeutics (CORT) United States $7.429B 61.12
Stevanato Group S.p.A (STVN) Italy $7.111B 44.98
Madrigal Pharmaceuticals (MDGL) United States $6.563B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $6.099B 0.00
Ionis Pharmaceuticals (IONS) United States $5.664B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $3.989B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.975B 0.00
Hypermarcas (HYPMY) Brazil $2.939B 19.33
Catalyst Pharmaceuticals (CPRX) United States $2.870B 10.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.429B 13.75
NewAmsterdam Pharma (NAMS) Netherlands $2.269B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.000B 0.00
Indivior (INDV) United States $1.915B 8.29
Centessa Pharmaceuticals (CNTA) United Kingdom $1.653B 0.00
Dyne Therapeutics (DYN) United States $1.638B 0.00
Evotec AG (EVO) Germany $1.516B 0.00
ARS Pharmaceuticals (SPRY) United States $1.512B 0.00
Ocular Therapeutix (OCUL) United States $1.391B 0.00
Guardian Pharmacy Services (GRDN) United States $1.246B 0.00
Harrow (HROW) United States $1.112B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.105B 22.00
Enliven Therapeutics (ELVN) United States $1.075B 0.00
Collegium Pharmaceutical (COLL) United States $0.938B 5.15
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.926B 0.00
Ardelyx (ARDX) United States $0.861B 0.00
Cronos Group (CRON) Canada $0.744B 0.00
Elite Pharmaceuticals (ELTP) United States $0.718B 0.00
Xeris Biopharma Holdings (XERS) United States $0.680B 0.00
Xencor (XNCR) United States $0.654B 0.00
KalVista Pharmaceuticals (KALV) United States $0.644B 0.00
AleAnna (ANNA) United States $0.592B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Altimmune (ALT) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.552B 0.00
USANA Health Sciences (USNA) United States $0.550B 12.49
Verve Therapeutics (VERV) United States $0.549B 0.00
Bioventus (BVS) United States $0.544B 13.75
Theravance Biopharma (TBPH) United States $0.535B 0.00
Tourmaline Bio (TRML) United States $0.505B 0.00
Zevra Therapeutics (ZVRA) United States $0.499B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
Oruka Therapeutics (ORKA) United States $0.470B 0.00
Siga Technologies (SIGA) United States $0.454B 9.70
Organogenesis (ORGO) United States $0.389B 0.00
Savara (SVRA) United States $0.382B 0.00
Liminatus Pharma (LIMN) United States $0.375B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 9.87
Aquestive Therapeutics (AQST) United States $0.340B 0.00
Heron Therapeutics (HRTX) United States $0.294B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 25.10
Nanobiotix S.A (NBTX) France $0.252B 0.00
ProKidney (PROK) United States $0.245B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.235B 0.00
Esperion Therapeutics (ESPR) United States $0.232B 0.00
MediWound (MDWD) Israel $0.221B 0.00
OmniAb (OABI) United States $0.217B 0.00
4D Molecular Therapeutics (FDMT) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.197B 0.00
Larimar Therapeutics (LRMR) United States $0.184B 0.00
Aldeyra Therapeutics (ALDX) United States $0.167B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.160B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Aclaris Therapeutics (ACRS) United States $0.159B 0.00
Journey Medical (DERM) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.146B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Lexeo Therapeutics (LXEO) United States $0.131B 0.00
Korro Bio (KRRO) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.121B 0.00
Achieve Life Sciences (ACHV) Canada $0.113B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Champions Oncology (CSBR) United States $0.106B 17.30
Fractyl Health (GUTS) United States $0.101B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Wellgistics Health (WGRX) United States $0.096B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Galectin Therapeutics (GALT) United States $0.087B 0.00
Unicycive Therapeutics (UNCY) United States $0.082B 0.00
Surrozen (SRZN) United States $0.081B 0.00
Nutriband (NTRB) United States $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 60.89
Inotiv (NOTV) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
ESSA Pharma (EPIX) Canada $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Context Therapeutics (CNTX) United States $0.056B 0.00
PMV Pharmaceuticals (PMVP) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.054B 0.00
Metagenomi (MGX) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Klotho Neurosciences (KLTO) United States $0.052B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
FibroGen (FGEN) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.021B 0.00
BioVie (BIVI) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.17
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
GlycoMimetics (GLYC) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00